IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS
Publication
, Conference
Desjardins, A; Gromeier, M; Friedman, H; Landi, D; Friedman, A; Ashley, DM; Curry, W; Butowski, N; Sloan, A; Wen, P; Cavaliere, R; Gerstner, E ...
Published in: Neuro-Oncology
November 12, 2021
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 12, 2021
Volume
23
Issue
Supplement_6
Start / End Page
vi97 / vi97
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Gromeier, M., Friedman, H., Landi, D., Friedman, A., Ashley, D. M., … Bigner, D. (2021). IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. In Neuro-Oncology (Vol. 23, pp. vi97–vi97). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noab196.385
Desjardins, Annick, Matthias Gromeier, Henry Friedman, Daniel Landi, Allan Friedman, David M. Ashley, William Curry, et al. “IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS.” In Neuro-Oncology, 23:vi97–vi97. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab196.385.
Desjardins A, Gromeier M, Friedman H, Landi D, Friedman A, Ashley DM, et al. IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. In: Neuro-Oncology. Oxford University Press (OUP); 2021. p. vi97–vi97.
Desjardins, Annick, et al. “IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS.” Neuro-Oncology, vol. 23, no. Supplement_6, Oxford University Press (OUP), 2021, pp. vi97–vi97. Crossref, doi:10.1093/neuonc/noab196.385.
Desjardins A, Gromeier M, Friedman H, Landi D, Friedman A, Ashley DM, Curry W, Butowski N, Sloan A, Wen P, Cavaliere R, Gerstner E, Berger M, Buerki R, Chiocca EA, Sauvageau E, Kelly A, Nichols WG, Mixson L, Dickinson A, Orr K, Learn C, Bigner D. IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. Neuro-Oncology. Oxford University Press (OUP); 2021. p. vi97–vi97.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 12, 2021
Volume
23
Issue
Supplement_6
Start / End Page
vi97 / vi97
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences